E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia
2002

HPV E7 Proteins and p73 in Cervical Cancer

Sample size: 78 publication Evidence: moderate

Author Information

Author(s): Brooks L A, Sullivan A, O'Nions J, Bell A, Dunne B, Tidy J A, Evans D J, Osin P, Vousden K H, Gusterson B, Farrell P J, Storey A, Gasco M, Sakai T, Crook T

Primary Institution: Ludwig Institute for Cancer Research, St Mary's Hospital Medical School, London, UK

Hypothesis

Does the E7 protein from oncogenic HPV types transactivate p73 and contribute to cervical intraepithelial neoplasia?

Conclusion

The study found that E7 proteins from oncogenic HPV types significantly increase the expression of p73 in cervical tissues, suggesting a role in cervical cancer development.

Supporting Evidence

  • E7 proteins from high-risk HPV types activate the p73 promoter more effectively than low-risk types.
  • Over-expression of p73 was observed in 82% of cervical SCC cases analyzed.
  • Expression of p73 was detected throughout neoplastic epithelium, unlike in normal tissue.

Takeaway

The study shows that a virus from HPV can make a protein called p73 work too much, which might help cause cervical cancer.

Methodology

The study used transient assays in cell lines and analyzed cervical tissue specimens for p73 expression through RT-PCR and immunocytochemistry.

Limitations

The study primarily focused on specific HPV types and may not generalize to all cervical cancers.

Participant Demographics

Cervical tissue specimens from patients with varying grades of cervical intraepithelial neoplasia and squamous cell carcinoma.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6600033

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication